BioAtla

BioAtla is a clinical-stage biotechnology company that researches and develops antibody therapeutics for the treatment of cancer.

Business Model:

Revenue: $29.6M

Employees: 51-200

Rankings

Detailed BioAtla Information

Geographic Data

BioAtla headquarters map

Address: 11085 Torreyana Road

City: San Diego

State: CA

Zip: 92121

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$75M

Raised Total:

$227M

Metrics

4,587,530Website Global Rank

2,015Website Monthly Traffic

Twitter Followers

Description

BioAtla is a clinical-stage biotechnology company that researches and develops antibody therapeutics for the treatment of cancer.

Contact Phone:
+18585580708

Contact Email:

BioAtla went public on 12/15/2020 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
12/15/2020

IPO Valuation:
$578M

Ticker Symbol:
BCAB

IPO Price:
$18/share

Amount Raised:
$189M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
2/2017 Exuma Biotech Series A 0
2/2017 Exuma Biotech Series A 0
Announced Date Transaction Number of Investors Money Raised Lead Investors
1/2016 Equity $15M
3/2015 Equity $39M
1/2016 Venture Round 1 $45M Global BIO Impact Fund
Global BIO Impact Fund
6/2015 Venture Round $30M
11/2022 Post-IPO Equity $65M
9/2021 Post-IPO Equity $0 Cormorant Asset Management
Deerfield
Great Point Partners
HBM Healthcare Investments AG
Hudson Bay Capital Management
Ikarian Capital
Monashee Investment Management
Pappas Capital
Soleus Capital
Sphera Global Healthcare Fund
Cormorant Asset Management
Deerfield
Great Point Partners
HBM Healthcare Investments AG
Hudson Bay Capital Management
Ikarian Capital
Monashee Investment Management
Pappas Capital
Soleus Capital
Sphera Global Healthcare Fund
1/2016 Debt $30M
7/2020 Series D $0 HBM Healthcare Investments AG
Soleus Capital
Pappas Capital
Pfizer Venture Investments
Janus Henderson Investors
Farallon Capital Management
Cormorant Asset Management
Boxer Capital
HBM Healthcare Investments AG
Soleus Capital
Pappas Capital
Pfizer Venture Investments
Janus Henderson Investors
Farallon Capital Management
Cormorant Asset Management
Boxer Capital
7/2015 Venture Round 1 $39M Temerity Capital Partners
11/2022 Post-IPO Equity $0 Vivo Capital
Soleus Capital
Janus Henderson Investors
EcoR1 Capital
Cormorant Asset Management
Adage Capital Management
Acuta Capital Partners
Vivo Capital
Soleus Capital
Janus Henderson Investors
EcoR1 Capital
Cormorant Asset Management
Adage Capital Management
Acuta Capital Partners
7/2020 Series D 8 $72.5M Soleus Capital
HBM Healthcare Investments
Farallon Capital Management, LLC
Pappas Capital
Boxer Capital
HBM Healthcare Investments AG
Soleus Capital
9/2021 Post-IPO Equity 10 $75M Cormorant Asset Management
Deerfield
Great Point Partners
HBM Healthcare Investments AG
Hudson Bay Capital Management
Ikarian Capital
Monashee Investment Management
Pappas Capital
Soleus Capital
Sphera Global Healthcare Fund
Cormorant Asset Management
Deerfield
Great Point Partners
HBM Healthcare Investments AG
Hudson Bay Capital Management
Ikarian Capital
Monashee Investment Management
Pappas Capital
Soleus Capital
Sphera Global Healthcare Fund
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research